
Anyone wishing to revisit our feature on this research can do so here: mstranslate.com.au/antiviral…

Providing accurate, unbiased, easy to understand information about multiple sclerosis research and news worldwide. #MultipleSclerosis #MS

Anyone wishing to revisit our feature on this research can do so here: mstranslate.com.au/antiviral…

Recently, we wrote an article about a potential treatment for #MultipleSclerosis that had shown promising results in animal models. @UVA has now posted an interview with the lead researcher in this study, who discusses more about this exciting work. #MS news.virginia.edu/content/qa…

Many living with #MultipleSclerosis describe the "crap gap" - the time just before the next round of treatment when symptoms feel much worse. In this article, @EverydayHealth explore the causes of this phenomenon & what can potentially be done about it. everydayhealth.com/neurologi…

Patient Community Day 2026 closed with a bonus session addressing questions submitted by the global #MultipleSclerosis, NMOSD & MOGAD communities both prior to & during the event. A wonderful way to conclude another interesting, informative & engaging PCD! youtu.be/-TzIvfWaS08?si=J3VI…

People living with #MultipleSclerosis, NMOSD & MOGAD sit at the heart of Patient Community Day (PCD). This next event recording looks at the outcomes & insights shared at #MSToronto2026 & PCD through the eyes of those with lived experience. #MS youtu.be/H4pkR_Jx3kE?is=mbjR…

Today’s Patient Community Day recording is of Session 3, which explored some of the hot topics in #MultipleSclerosis research, incl. remyelination, ageing, brain health, other health conditions (comorbidities), hormones & reproduction. #MSToronto2026 #MS youtu.be/QF-luwgIhqU?si=i7ff…

It’s our pleasure to share recordings from Patient Community Day 2026! First up is Session 1: Clinical Updates in #MultipleSclerosis, covering topics incl. CAR T-cell therapy, BTK inhibitors & treatment discontinuation. Watch it here: youtube.com/watch?v=nhdRddU4… #MSToronto2026

HEAL-MS data suggested activity levels can decline before disability worsening occurs, suggesting it could provide an early sign of future changes. Wearables may support traditional measures & provide a more complete picture of how #MultipleSclerosis is changing over time. [2/2]

Digital assessments were an interesting topic at #MSToronto2026, with discussion around how wearable #technology could capture more than just step counts - including patterns of activity, sleep & bladder function. [1/2]

However, there was also encouraging news, with positive updates for fenebrutinib and new positive trial results for remibrutinib providing plenty of reason for continued optimism. [2/2]

One of the big surprises from #MSToronto2026: @sanofi will not pursue US approval of tolebrutinib. This was met with disappointment given the excitement around BTKi & their potential to address aspects of #MultipleSclerosis not adequately targeted by current treatments. [1/2]

🎙️ Day Three at MSToronto2026 – and it’s time to bring an extraordinary week of MS science together. For the final episode in our special MSToronto2026 podcast series, Jaume Sastre-Garriga, @ECTRIMS Executive Committee member, joins host Brett Drummond direct from Toronto. First, they unpack some of the key insights and conversations from Day Three. Then they step back and look at the bigger picture. 🔬 What stood out across the Joint Meeting, including at the Late Breaking Abstract session? 💡 Which ideas and developments could have lasting significance? 🌎 And as the MS community prepares to leave Toronto, 𝐰𝐡𝐚𝐭 𝐝𝐨 𝐰𝐞 𝐭𝐚𝐤𝐞 𝐰𝐢𝐭𝐡 𝐮𝐬 – 𝐚𝐧𝐝 𝐰𝐡𝐞𝐫𝐞 𝐝𝐨 𝐰𝐞 𝐠𝐨 𝐧𝐞𝐱𝐭? After a week of new research, debate, collaboration and conversation, this final episode is a chance to reflect on 𝐰𝐡𝐚𝐭 𝐌𝐒𝐓𝐨𝐫𝐨𝐧𝐭𝐨2026 𝐡𝐚𝐬 𝐭𝐨𝐥𝐝 𝐮𝐬 𝐚𝐛𝐨𝐮𝐭 𝐰𝐡𝐞𝐫𝐞 𝐭𝐡𝐞 𝐌𝐒 𝐟𝐢𝐞𝐥𝐝 𝐢𝐬 𝐭𝐨𝐝𝐚𝐲 – 𝐚𝐧𝐝 𝐰𝐡𝐞𝐫𝐞 𝐢𝐭 𝐦𝐚𝐲 𝐛𝐞 𝐡𝐞𝐚𝐝𝐢𝐧𝐠 𝐧𝐞𝐱𝐭. 🎧 𝐋𝐢𝐬𝐭𝐞𝐧 𝐭𝐨 𝐌𝐒𝐓𝐨𝐫𝐨𝐧𝐭𝐨2026 𝐃𝐚𝐲 𝐓𝐡𝐫𝐞𝐞 𝐧𝐨𝐰 – 𝐚𝐧𝐝 𝐜𝐚𝐭𝐜𝐡 𝐮𝐩 𝐨𝐧 𝐭𝐡𝐞 𝐜𝐨𝐦𝐩𝐥𝐞𝐭𝐞 🟢 𝐒𝐩𝐨𝐭𝐢𝐟𝐲: bit.ly/4sFGWt3 🍎 𝐀𝐩𝐩𝐥𝐞: apple.co/4ibfyxX 🖥️ 𝐖𝐞𝐛𝐬𝐢𝐭𝐞: bit.ly/4siotCl Featuring Jaume Sastre-Garriga, ECTRIMS Executive Committee and CEMCAT (Centre d'Esclerosi Múltiple de Catalunya), Vall d'Hebron Barcelona Hospital Campus @cemcat_em, @vallhebron, @ECTRIMS, @ACTRIMS, @MTCC_Events, @SeeTorontoNow #ECTRIMS #MSToronto2026 #ECTRIMSPodcast #MultipleSclerosis #MSResearch #Neurology

🎙️ From Day Two at #MSToronto2026, Tim Coetzee of @mssociety and Pam Valentine of @MSCanOfficial join us to talk research, collaboration – and turning scientific progress into real-world impact. 🎧 𝐋𝐢𝐬𝐭𝐞𝐧 𝐧𝐨𝐰: 🟢 𝐒𝐩𝐨𝐭𝐢𝐟𝐲: open.spotify.com/episode/04R… 🍎 𝐀𝐩𝐩𝐥𝐞: podcasts.apple.com/us/podcas… 🖥️ 𝐖𝐞𝐛𝐬𝐢𝐭𝐞: ectrims.eu/podcast/mstoronto… #ECTRIMSPodcast #MSResearch

𝐃𝐚𝐲 𝐎𝐧𝐞 𝐚𝐭 #𝐌𝐒𝐓𝐨𝐫𝐨𝐧𝐭𝐨2026 – 𝐚𝐧𝐝 𝐰𝐞’𝐫𝐞 𝐭𝐚𝐤𝐢𝐧𝐠 𝐲𝐨𝐮 𝐢𝐧𝐬𝐢𝐝𝐞 𝐨𝐧𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐦𝐞𝐞𝐭𝐢𝐧𝐠’𝐬 𝐡𝐞𝐚𝐝𝐥𝐢𝐧𝐞 𝐥𝐞𝐜𝐭𝐮𝐫𝐞𝐬. Our special MSToronto2026 podcast series continues with Daniel Reich – the MSToronto2026 Lecturer – as he joins host Brett Drummond to reflect on some of the key takeaways from the first full day in Toronto. Then, we go deeper. What if imaging could help us connect the dots in MS - from disease mechanisms to networks to the person living with MS? Fresh from his lecture, Unifying Multiple Sclerosis: Imaging from Teams to Tissue to Biology, Daniel takes the conversation beyond the stage: • What can imaging reveal about the biology driving MS? • How is it changing the way we understand what is happening in the brain? • And where could the next generation of imaging take MS research? Recorded direct from Toronto, hear Daniel and Brett unpack Day One – and go beyond the lecture - with one of the leading figures in MS imaging research. 🎧 𝐋𝐢𝐬𝐭𝐞𝐧 𝐭𝐨 𝐨𝐮𝐫 𝐃𝐚𝐲 𝐎𝐧𝐞 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬 𝐞𝐩𝐢𝐬𝐨𝐝𝐞 𝐧𝐨𝐰 – 𝐚𝐧𝐝 𝐟𝐨𝐥𝐥𝐨𝐰 𝐭𝐡𝐞 𝐄𝐂𝐓𝐑𝐈𝐌𝐒 𝐏𝐨𝐝𝐜𝐚𝐬𝐭 𝐚𝐬 𝐰𝐞 𝐛𝐫𝐢𝐧𝐠 𝐲𝐨𝐮 𝐧𝐞𝐰 𝐞𝐩𝐢𝐬𝐨𝐝𝐞𝐬 𝐭𝐡𝐫𝐨𝐮𝐠𝐡𝐨𝐮𝐭 𝐌𝐒𝐓𝐨𝐫𝐨𝐧𝐭𝐨2026. 🟢 𝐒𝐩𝐨𝐭𝐢𝐟𝐲: bit.ly/3TV02hQ 🍎 𝐀𝐩𝐩𝐥𝐞: apple.co/4ib2tEN 🖥️ 𝐖𝐞𝐛𝐬𝐢𝐭𝐞: bit.ly/4sh9DfB Featuring Daniel Reich, National Institute of Neurological Disorders and Stroke (NINDS), The National Institutes of Health. @ECTRIMS @ACTRIMS #ECTRIMS #ACTRIMS #MSToronto2026 #ECTRIMSPodcast #MultipleSclerosis #MSResearch #Neuroimaging #Neurology

𝐃𝐢𝐫𝐞𝐜𝐭 𝐟𝐫𝐨𝐦 𝐓𝐨𝐫𝐨𝐧𝐭𝐨 – 𝐭𝐡𝐞 𝐜𝐨𝐧𝐯𝐞𝐫𝐬𝐚𝐭𝐢𝐨𝐧𝐬 𝐡𝐚𝐯𝐞 𝐚𝐥𝐫𝐞𝐚𝐝𝐲 𝐛𝐞𝐠𝐮𝐧, 𝐚𝐧𝐝 𝐰𝐞’𝐯𝐞 𝐠𝐨𝐭 𝐭𝐡𝐞𝐦 𝐨𝐧 𝐫𝐞𝐜𝐨𝐫𝐝! 🎙️ The @ECTRIMS Podcast is coming to you from #MSToronto2026, with a special series of episodes recorded throughout the Joint Meeting – bringing you highlights, reactions and conversations with some of the leading voices in MS and neuroimmunology. And we’re starting with 𝐏𝐫𝐞-𝐃𝐚𝐲. Ann Yeh joins #ECTRIMSPodcast host @MStranslate Brett Drummond to unpack the discussions and highlights from a day dedicated to specialised topics across MS and related neuroinflammatory diseases. What stood out? What should we be paying attention to? And which conversations are already setting the stage for the days ahead? 🎧 𝐒𝐭𝐚𝐫𝐭 𝐲𝐨𝐮𝐫 𝐌𝐒𝐓𝐨𝐫𝐨𝐧𝐭𝐨2026 𝐰𝐞𝐞𝐤 𝐰𝐢𝐭𝐡 𝐮𝐬 – 𝐥𝐢𝐬𝐭𝐞𝐧 𝐭𝐨 𝐭𝐡𝐞 𝐟𝐢𝐫𝐬𝐭 𝐞𝐩𝐢𝐬𝐨𝐝𝐞 𝐢𝐧 𝐨𝐮𝐫 𝐬𝐩𝐞𝐜𝐢𝐚𝐥 𝐉𝐨𝐢𝐧𝐭 𝐌𝐞𝐞𝐭𝐢𝐧𝐠 𝐩𝐨𝐝𝐜𝐚𝐬𝐭 𝐬𝐞𝐫𝐢𝐞𝐬 𝐧𝐨𝐰. 🟢 𝐒𝐩𝐨𝐭𝐢𝐟𝐲: bit.ly/483O6xt 🍎 𝐀𝐩𝐩𝐥𝐞: apple.co/4k8Y2Nr 🖥️ 𝐖𝐞𝐛𝐬𝐢𝐭𝐞: bit.ly/4sosdT6 Featuring Ann Yeh, The Hospital for Sick Children(SickKids) / University of Toronto. @ECTRIMS #ECTRIMSPodcast #MSResearch

Day 1 of #MSTORONTO2026 is underway & we’re starting with a topic that is critical to people living with #MultipleSclerosis - brain health! Dr Lara Pilutti from @ottawa_of is currently presenting on the key role that exercise plays in optimising outcomes. @ECTRIMS @ACTRIMS #MS